Evoke Wealth, LLC Abb Vie Inc. Transaction History

Evoke Wealth, LLC

$3.68 Trillion
Q3 2024

A detailed history of Evoke Wealth, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Evoke Wealth, LLC holds 19,926 shares of ABBV stock, worth $3.59 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

19,926

Holding current value

$3.59 Million

% of portfolio

0.11%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $3.26 Million - $3.97 Million	19,926 New	19,926 $3.94 Billion
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $198,656 - $226,350	1,243 Added 6.72%	19,748 $3.6 Million
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $357,760 - $402,922	-2,600 Reduced 12.32%	18,505 $2.87 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $54,103 - $62,633	405 Added 1.96%	21,105 $3.15 Million
Q2 2023 Aug 09, 2023	BUY	$132.51 - $164.9 $29,417 - $36,607	222 Added 1.08%	20,700 $2.79 Million
Q1 2023 May 08, 2023	BUY	$144.61 - $166.54 $48,733 - $56,123	337 Added 1.67%	20,478 $3.26 Million
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $5,394 - $6,468	39 Added 0.19%	20,141 $3.26 Million
Q3 2022 Nov 07, 2022	BUY	$134.21 - $153.93 $1,342 - $1,539	10 Added 0.05%	20,102 $2.7 Million
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $8,945 - $11,372	-65 Reduced 0.32%	20,092 $3.08 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $370,071 - $459,155	-2,804 Reduced 12.21%	20,157 $3.27 Million
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $138,584 - $175,349	-1,290 Reduced 5.32%	22,961 $3.11 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $14,151 - $16,063	-133 Reduced 0.55%	24,251 $2.62 Million
Q2 2021 Aug 05, 2021	BUY	$105.21 - $117.21 $593,173 - $660,829	5,638 Added 30.08%	24,384 $2.75 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $970,929 - $1.07 Million	9,491 Added 102.55%	18,746 $2.03 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $59,804 - $80,741	743 Added 8.73%	9,255 $992,000
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $9,879 - $11,595	115 Added 1.37%	8,512 $746,000
Q2 2020 Aug 10, 2020	BUY	$73.37 - $98.18 $272,349 - $364,444	3,712 Added 79.23%	8,397 $824,000
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $208,270 - $315,763	-3,229 Reduced 40.8%	4,685 $357 Million
Q4 2019 Feb 07, 2020	BUY	$72.13 - $90.25 $28,419 - $35,558	394 Added 5.24%	7,914 $701 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $473,609 - $569,414	7,520 New	7,520 $569 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evoke Wealth, LLC with notifications on news.

Account